Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-30

FDA Approved: PATADAY ONCE DAILY RELIEF — Original Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approved Pataday Once Daily Relief (olopatadine hydrochloride) from Alcon Laboratories in an Original Application for the treatment of allergic conjunctivit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)

Snippet

ORIG AP for PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)